Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 322 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Active, Not Recruiting

Agriculture Health Study

NCT00352924

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Genital Diseases, +25 more
Locations
  • Research Triangle Institute Research Triangle Park, North Carolina, United States
View Trial Details
Active, Not Recruiting

A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT05083169

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

NCT05556798

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

NCT03896737

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
Locations
  • Hradec Kralove-University Hospital Hradec Kralove Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Ostrava Ostrava, Czechia
  • University Hospital Ostrava Ostrava, Czechia
View all 24 locations
View Trial Details
Active, Not Recruiting

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

NCT04564703

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Bordeau, France
  • Centre Hospitalier Universitaire de Dijon Dijon, France
  • CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE Nantes, France
  • CHU Hôtel-Dieu Nantes, France
View all 22 locations
View Trial Details
Active, Not Recruiting

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)

NCT04483739

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Het Ziekenhuisnetwerk Antwerpen - Department of Hematology Antwerp, Belgium
  • Fakultni Nemocnice Brno - Internal Hematology and Oncology Clinic Brno, Czechia
  • Fakultni Nemocnice Hradec Kralove - 4th Department of Internal Medicine Nový Hradec Králové, Czechia
  • Fakultni Nemocnice Ostrava - Department of Haematooncology Ostrava, Czechia
View all 41 locations
View Trial Details

Related conditions